Documents
Application Sponsors
BLA 761039 | COHERUS BIOSCIENCES INC | |
Marketing Status
Application Products
001 | INJECTABLE;INJECTION | 6MG/0.6ML | 0 | UDENYCA | PEGFILGRASTIM-CBQV |
FDA Submissions
TYPE 5; Type 5 - New Formulation or New Manufacturer | ORIG | 1 | AP | 2018-11-02 | STANDARD |
LABELING; Labeling | SUPPL | 3 | AP | 2020-02-12 | STANDARD |
LABELING; Labeling | SUPPL | 4 | AP | 2019-10-17 | STANDARD |
LABELING; Labeling | SUPPL | 10 | AP | 2021-06-07 | STANDARD |
EFFICACY; Efficacy | SUPPL | 14 | AP | 2022-11-28 | STANDARD |
Submissions Property Types
ORIG | 1 | Null | 6 |
SUPPL | 3 | Null | 6 |
SUPPL | 4 | Null | 6 |
SUPPL | 10 | Null | 6 |
SUPPL | 14 | Null | 6 |
CDER Filings
COHERUS BIOSCIENCES INC
cder:Array
(
[0] => Array
(
[ApplNo] => 761039
[companyName] => COHERUS BIOSCIENCES INC
[docInserts] => ["",""]
[products] => [{"drugName":"UDENYCA","activeIngredients":"PEGFILGRASTIM-CBQV","strength":"6MG\/0.6ML","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Prescription","te":"None","rld":"No","rs":"No"}]
[labels] => [{"actionDate":"02\/12\/2020","submission":"SUPPL-3","supplementCategories":"Labeling-Container\/Carton Labels","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2020\\\/761039s003lbl.pdf\"}]","notes":""},{"actionDate":"02\/12\/2020","submission":"SUPPL-3","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2020\\\/761039s003lbl.pdf\"}]","notes":""},{"actionDate":"02\/12\/2020","submission":"SUPPL-3","supplementCategories":"Labeling-Patient Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2020\\\/761039s003lbl.pdf\"}]","notes":""},{"actionDate":"04\/16\/2019","submission":"SUPPL-1","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2019\\\/761039s001lbl.pdf\"}]","notes":""},{"actionDate":"11\/02\/2018","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2018\\\/761039s000lbl.pdf\"}]","notes":""}]
[originalApprovals] => [{"actionDate":"11\/02\/2018","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"N\/A","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2018\\\/761039s000lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2018\\\/761039Orig1s000ltr.pdf\"},{\"name\":\"Review\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/nda\\\/2018\\\/761039Orig1s000TOC.cfm\"}]","notes":">"}]
[supplements] => [{"actionDate":"10\/17\/2019","submission":"SUPPL-4","supplementCategories":"Supplement","inserts":"[{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2019\\\/761039Orig1s004ltr.pdf\"}]","notes":"> Label is not available on this site."},{"actionDate":"02\/12\/2020","submission":"SUPPL-3","supplementCategories":"Supplement","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2020\\\/761039s003lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2020\\\/761039Orig1s003ltr.pdf\"}]","notes":">"},{"actionDate":"04\/16\/2019","submission":"SUPPL-1","supplementCategories":"Supplement","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2019\\\/761039s001lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2019\\\/761039Orig1s001ltr.pdf\"}]","notes":">"}]
[actionDate] => 2020-02-12
)
)